Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

被引:9
作者
Chronopoulos, A. [2 ]
Pleyer, U. [1 ]
Mockenhaupt, M. [3 ]
机构
[1] Univ Augenklin, D-13353 Berlin, Germany
[2] Univ Med, Klin Augenheilkunde, Berlin, Germany
[3] Univ Hautklinik Freiburg, Dokumentationszentrum Schwerer Hautreaktionen dZh, Freiburg, Germany
关键词
cornea; conjunctiva; pathology; Stevens-Johnson syndrome; toxic epidermal necrolysis; ocular manifestation; ERYTHEMA MULTIFORME; INTRAVENOUS IMMUNOGLOBULIN; SURFACE DISEASE; MANIFESTATIONS; TRANSPLANTATION; MANAGEMENT; MORTALITY; PATTERNS; EUROSCAR; THERAPY;
D O I
10.1055/s-0031-1299530
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare severe reactions of skin and mucous membranes. They are considered as a single disease entity with differing severities and are mainly induced by drugs, less frequently by infections. In 50 % of the patients ocular complications occur, which can lead to blindness in the absence of immediate ophthalmological treatment. The acute pattern, the unpredictable course and extreme variations in the manifestation of complications require an interdisciplinary treatment. Early diagnosis and initiation of an intensive lubricating and anti-inflammatory surface care are of utmost importance for the best visual outcome. This article is intended to help ophthalmologists towards a better understanding and interpretation of clinical signs of these conditions with the goal to achieve substantial improvements in visual outcome and of course the patient's quality of life
引用
收藏
页码:534 / 539
页数:6
相关论文
共 41 条
[1]   Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis - Results of an international prospective study [J].
Auquier-Dunant, A ;
Mockenhaupt, M ;
Naldi, L ;
Correia, O ;
Schroder, W ;
Roujeau, JC .
ARCHIVES OF DERMATOLOGY, 2002, 138 (08) :1019-1024
[2]   Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis - A prospective noncomparative study showing no benefit on mortality or progression [J].
Bachot, N ;
Revuz, J ;
Roujeau, JC .
ARCHIVES OF DERMATOLOGY, 2003, 139 (01) :33-36
[3]   SCORTEN: A severity-of-illness score for toxic epidermal necrolysis [J].
Bastuji-Garin, S ;
Fouchard, N ;
Bertocchi, M ;
Roujeau, JC ;
Revuz, J ;
Wolkenstein, P .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (02) :149-153
[4]   CLINICAL CLASSIFICATION OF CASES OF TOXIC EPIDERMAL NECROLYSIS, STEVENS-JOHNSON SYNDROME, AND ERYTHEMA MULTIFORME [J].
BASTUJIGARIN, S ;
RZANY, B ;
STERN, RS ;
SHEAR, NH ;
NALDI, L ;
ROUJEAU, JC .
ARCHIVES OF DERMATOLOGY, 1993, 129 (01) :92-96
[5]   Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis - Acute ocular manifestations, causes, and management [J].
Chang, Yi-Sheng ;
Huang, Fu-Chin ;
Tseng, Sung-Huei ;
Hsu, Chao-Kai ;
Ho, Chung-Liang ;
Sheu, Hamm-Ming .
CORNEA, 2007, 26 (02) :123-129
[6]   Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis [J].
Chung, Wen-Hung ;
Hung, Shuen-Iu ;
Yang, Jui-Yung ;
Su, Shih-Chi ;
Huang, Shien-Ping ;
Wei, Chun-Yu ;
Chin, See-Wen ;
Chiou, Chien-Chun ;
Chu, Sung-Chao ;
Ho, Hsin-Chun ;
Yang, Chih-Hsun ;
Lu, Chi-Fang ;
Wu, Jer-Yuarn ;
Liao, You-Di ;
Chen, Yuan-Tsong .
NATURE MEDICINE, 2008, 14 (12) :1343-1350
[7]   The natural history of Stevens-Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy [J].
De Rojas, M. Victoria ;
Dart, John K. G. ;
Saw, Valerie P. J. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (08) :1048-1053
[8]   Allo-limbal transplantation in patients with limbal stem cell deficiency [J].
Dua, HS ;
Azuara-Blanco, A .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1999, 83 (04) :414-419
[9]  
Edward J, 1996, OCULAR INFECT IMMUNI
[10]   Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IVIg) - Clinical experience to date [J].
Faye, O ;
Roujeau, JC .
DRUGS, 2005, 65 (15) :2085-2090